PHARMACY AND THERAPEUTICS COMMITTEE
- Section 414.351 - Definitions for ORS 414.351 to 414.414
- Section 414.353 - Committee established; membership
- Section 414.354 - Meetings; advisory committees; public notice and testimony
- Section 414.355 - [Repealed]
- Section 414.356 - Executive session
- Section 414.359 - Mental Health Clinical Advisory Group
- Section 414.360 - [Repealed]
- Section 414.361 - [Operative until 1/2/2026] Committee to advise and make recommendations on drug utilization review standards and interventions; preferred drug list
- Section 414.361 - [Operative 1/2/2026] Committee to advise and make recommendations on drug utilization review standards and interventions; preferred drug list
- Section 414.364 - Intervention approaches
- Section 414.365 - [Repealed]
- Section 414.369 - Prospective drug use review program
- Section 414.370 - [Repealed]
- Section 414.371 - Retrospective drug use review program
- Section 414.372 - Pharmacy lock-in program; rules
- Section 414.375 - [Repealed]
- Section 414.380 - [Repealed]
- Section 414.381 - Annual reports; educational materials; procedures to protect confidential information
- Section 414.382 - Requirements for annual report
- Section 414.385 - [Repealed]
- Section 414.390 - [Repealed]
- Section 414.395 - [Repealed]
- Section 414.400 - [Repealed]
- Section 414.410 - [Repealed]
- Section 414.414 - Use and disclosure of confidential information
- Section 414.415 - [Repealed]
- Section 414.420 - [Renumbered]
- Section 414.422 - [Renumbered]
- Section 414.424 - [Renumbered]